Legend Biotech (LEGN) Other Working Capital Changes (2020 - 2026)

Legend Biotech (LEGN) has 6 years of Other Working Capital Changes data on file, last reported at $1.3 million in Q3 2025.

• Quarterly Other Working Capital Changes rose 6.12% year-over-year to $1.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.5 million (up 2772.83% YoY) and the FY2022 annual result came in at -$163000.0, down 3.16% from the prior year.
• Other Working Capital Changes eased to $1.3 million in Q3 2025, from $9.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $12.2 million in Q1 2023 to a low of -$50.6 million in Q4 2022.
• A 5-year average of -$15.4 million and a median of -$12.9 million in 2023 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 242600.0% in 2024, down 135244.44% in 2024.
• Tracing LEGN's Other Working Capital Changes over 5 years: stood at -$158000.0 in 2021, then slipped by 3.16% to -$163000.0 in 2022, then slumped by 653.99% to -$1.2 million in 2023, then soared by 197.07% to $1.2 million in 2024, then grew by 6.12% to $1.3 million in 2025.
• The last three Other Working Capital Changes figures came in at $1.3 million (Q3 2025), $9.0 million (Q2 2025), and -$9.0 million (Q1 2025), per Business Quant data.